companiesSEC EDGAR
Outlook Therapeutics, Inc.
SEC EDGAR published this disclosure on 2026-07-21. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-085430
cik1649989
company nameOutlook Therapeutics, Inc.
form424B3